Switch to:
More From Other Websites
Is The New York Times Co (NYT) A Good Stock To Buy? Nov 28 2016
ETFs with exposure to Nektar Therapeutics : November 14, 2016 Nov 14 2016
Nektar Therapeutics to Present at Jefferies 2016 Global Healthcare Conference in London Nov 14 2016
NEKTAR THERAPEUTICS Financials Nov 11 2016
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 Nov 10 2016
Nektar Therapeutics Presents New Clinical Data from Ongoing Phase 1 Dose-Escalation Study of... Nov 09 2016
NEKTAR THERAPEUTICS Files SEC form 8-K, Other Events Nov 09 2016
Nektar (NKTR) Stock Up on Narrower-than-Expected Q3 Loss Nov 08 2016
Coverage initiated on Nektar Therapeutics by Aegis Capital Nov 08 2016
Cormorant Asset Management’s Bets on Alder Biopharmaceuticals Inc (ALDR) and Other Healthcare... Nov 07 2016
Edited Transcript of NKTR earnings conference call or presentation 3-Nov-16 9:00pm GMT Nov 04 2016
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report Nov 04 2016
Nektar reports 3Q loss Nov 03 2016
Nektar reports 3Q loss Nov 03 2016
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 03 2016
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2016 Nov 03 2016
Q3 2016 Nektar Therapeutics Earnings Release - After Market Close Nov 03 2016
Nektar to Announce Financial Results for the Third Quarter 2016 on Thursday, November 3, 2016, After... Nov 01 2016
Nektar to Hold Investor & Analyst Event at 2016 Society for Immunotherapy of Cancer Annual Meeting Oct 28 2016
Nektar Therapeutics Announces Upcoming Presentations at the 2016 Society for Immunotherapy of Cancer... Oct 28 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK